4
Changes in Ownership
Arcus Biosciences, Inc. Filed Acc 0001182473-25-000005
Chief Executive Officer sold 54,691 shares at an average $22.01 ($1,203,959)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ROSEN TERRY J Chief Executive Officer | 2025-12-16 | Sale 10b5-1 | −28,947 | $21.88 | $633,485 | 2,220,553 | D: show line 1 in the form |
| ROSEN TERRY J Chief Executive Officer | 2025-12-17 | Sale 10b5-1 | −25,744 | $22.16 | $570,474 | 2,194,809 | D: show line 2 in the form |
| Open-market sales · 54,691 sh · avg $22.01 · $1,203,959 | |||||||
Loading xslF345X05/wk-form4_1766097299.xml…